Bristol-Myers Squibb (BMY) has released an update to notify the public and investors about a regulation fd disclosure.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
On February 2, 2024, the Company made available a presentation on its financial and operating initiatives for the fourth quarter of 2023 and the full year, in conjunction with a conference call and webcast. The presentation, which includes non-GAAP financial information, is accompanied by reconciliations with GAAP measures and is furnished as part of a Current Report. The Company may remove the presentation from its website at any time, and the information provided is not considered filed under securities law nor is it an admission of materiality.
For further insights into BMY stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.